17 th Annual Meeting of JSHDF, Sept 3-4, 2011

Size: px
Start display at page:

Download "17 th Annual Meeting of JSHDF, Sept 3-4, 2011"

Transcription

1 17 th Annual Meeting of JSHDF, Sept 3-4, 2011 Sug Kyun Shin 1, JY Moon 2, SW Han 3, DH Yang 4, SH Lee 2, HC Park 5, JK Kim 6 and YI Jo 7 1 Nephrology, NHIC Ilsan Hospital, 2 Kyunghee University Hospital at Gangdong, 3 Hanyang University Guri Hospital, 4 Bundang CHA Hospital, 5 Yonsei University Gangnam Severance Hospital, 7 Konkuk University Hospital; 6 Department of ENT, Konkuk University Hospital; Seoul, KOREA

2 Background-(1) It is well recognized that malnutrition is one of the main factors affecting morbidity and mortality in dialysis patients. Multiple factors may contribute to the development of malnutrition in patients with ESRD. - Alterations in taste and smell??? In elderly people in the general population, poor odor perception is associated with lower nutrient intake.

3 Background-(2) Although research into olfactory function in patients with ESRD is limited, olfactory function seems to be decreased in ESRD patients.

4 Griep MI et al. NDT 1997;12:

5 Background-(3) In patients with ESRD, impaired olfactory function may be associated with alterations in taste and smell and malnutrition? Raff AC et al. AJKD 2008;52:

6 Smell Score according to SGA * * p<0.001 vs. healthy controls * * Raff AC et al. AJKD 2008;52:

7 Background-(4) The cause of olfactory dysfunction in ESRD??? The effect of dialysis on olfactory function in ESRD??? Only a few researches about olfactorydys function in ESRD have been reported.

8 Smell Studies in Pts with ESRD, CKD, TXN Authors Year Journal No. of Subjects 1 Raff et al AJKD Controls 18, HD 31 2 Jo et al KJN Controls 20, CKD 20, HD 28, PD 22 3 Fransnelli et al Am J Rhinol Controls 15, CKD 15, HD 49 4 Griepet al NDT Controls 101, CKD 19, HD 38, PD 16, TXN 28 5 Corwin et al Neuropsychol. Controls 15, HD 14 6 Conrad et al Nephron Controls 10, HD 15 7 Vremanet al Nephron Controls 48, CKD 7, HD 26 8 Schiffman et al Physiol Behav Controls 16, HD 11

9 Griep MI et al. NDT 1997;12:

10 Smell Scores in Pre-dialysis & Dialysis Pts. Jo YI et al. Kor J Nephrol 2002;21:

11 Distribution of Total Kt/V and Smell Scores R= P= Jo YI et al. Kor J Nephrol 2002;21:

12 Background-(5) Previous cross-sectional studies showed that. (1) Olfactory function is impaired in ESRD patients. (2) Odor perception of ESRD patients receiving dialysis may be not differ with that of healthy controls. (3) Odor perception is fully restored to that of healthy controls after renal transplantation.

13 Background-(6) These findings of previous studies suggest that. (1) Decreased olfactory function in ESRD is due to uremic toxins. (2) Impaired olfactory function is fully reversible with complete resolution of the uremic state. However, there was no prospective study following initiation of dialysis on olfactory function in ESRD patients.

14 Purpose This prospective observational study was designed to clarify the effect of dialysis on olfactory function of ESRD patients who initiate maintenance HD or PD.

15 Subjects & Methods A multicenter, prospective, observational study. Subjects : 71 ESRD patients who initiated dialysis from 2010 through 2011 at 6 hospitals. - Hemodialysis: n=34, age 58.3± Peritoneal dialysis: n=37, age 56.3±15.5

16 Study Design Smell test by CC-SIT : 0, 3, 6 months. Kt/V urea, i-pth : 0, 3, 6 months. Other routine laboratory study : monthly.

17 CC-SIT: Cross-Cultural Smell Identification Test

18 Inclusion Criteria 1. ESRD patients who initiated dialysis (hemodialysis or peritoneal dialysis) from 2010 through Intact mental status.

19 Exclusion Criteria 1. Obstructions in the nasal cavity 2. Inability to breath freely through the nostril. 3. Maxillary sinusitis. 4. Upper respiratory infection. 5. Cognitive deficits. 6. Alcohol abuse.

20 Statistical Analysis Expressed in mean±sd. SPSS 18.0 Analysis: (1) Parameteric test: Student t-test (2) Non-parametric test (Comparison of CC-SIT scores over times): Wilcoxon s Matched-Pairs Signed-Rank Test (3) Correlation: Pearson analysis.

21 Results

22 Baseline Characteristics-(1) HD PD p No. of Subjects (n) Male [n(%)] 17 (50.0%) 17 (44.4%) n.s. Age (years) 58.3± ±15.5 n.s. Causes of ESRD [n(%)] DM 19 (56.3%) 17 (47.2%) n.s. Hypertension 6 (18.7%) 11 (27.8%) n.s. Chronic GN 3 (6.3%) 2 (5.6%) n.s. Others/ Unknown 6 (18.7%) 7 (19.4%) n.s. Smoking status Current smoking (%) 43.7% 35.2% n.s.

23 Baseline Characteristics-(2) HD PD p Serum Cr (mg/dl) 7.1± ±3.0 n.s. egfr-mdrd (ml/min/1.73m 2 ) 7.8± ±4.9 n.s. Serum albumin (mg/dl) 3.3± ±0.4 n.s. Total cholesterol (mg/dl) 122.6± ±48.2 n.s. Hb (g/dl) 9.8± ±1.2 n.s. Ca (mg/dl) 7.7± ±0.9 n.s. P (mg/dl) 4.6± ±1.1 n.s. i-pth (pg/ml) 94.5± ±132.6 n.s. hs-crp (mg/dl) 0.3± ±0.1 n.s. HbA1C (%) 7.9± ±1.5 n.s.

24 Changes of Laboratory Results Over Time 0 month 3 month 6 month egfr-mdrd (ml/min/1.73m 2 ) 9.5± ± ±4.4 Kt/V urea (-) 1.3± ±0.8 Serum albumin (mg/dl) 2.9± ± ±0.2 Total cholesterol (mg/dl) 150.5± ± ±38.4 Hb (g/dl) 9.8± ± ±1.3 Ca (mg/dl) 8.2± ± ±0.5 P (mg/dl) 4.9± ± ±0.5 i-pth (pg/ml) 223.0± ± ±188.0 hs-crp (mg/dl) 0.3± ± ±0.2 HbA1C (%) 7.2± ± ±1.8

25 Smell Score at baseline: measured by CC-SIT Smell score Smell score at baseline = 8.2±2.3

26 Distribution of Smell Score according to GFR Smell score egfr-mdrd (ml/min/1.73m 2 )

27 Distribution of Smell Score according to Age Smell score Age (years) R= P= 0.002

28 Smell Score and Nutritional Status Albumin Total cholesterol

29 Smell Score according to Variable Factors Gender Diabetes Smell score Male p= Female Smell score DM p= Non-DM

30 Changes of Smell Score following Dialysis Smell score Baseline 3 month 6 month * Duration of dialysis * p=0.007 vs. baseline p=0.006 vs. baseline

31 Changes of Smell Score: HD vs. PD CC-SIT score at baseline Smell score HD p= PD Smell score Baseline 3 month 6 month * * p=0.043 vs. baseline of HD p=0.006 vs. baseline of HD p=0.036 vs. baseline of PD PD (n=36) HD (n=16)

32 Changes of Smell Score: DM vs. Non-DM CC-SIT score at baseline Smell score DM p= Non-DM

33 Changes of Smell Score: 60 vs. >60 yr-old CC-SIT score at baseline Smell score yr p= >60 yr * * p=0.011 vs. baseline of >60 yr p=0.018 vs. 3 month of >60 yr

34 Changes of Smell Score: Male vs. Female CC-SIT score at baseline Smell score Male Female * * p=0.041 vs. male at 6 mon

35 Summary-(1) 1. This study was the first prospective study on olfactory function in ESRD patients. 2. In the ESRD patients not receiving dialysis, (1) smell score which was measured by CC-SIT was negatively correlated with ages (r=-0.179, p=0.02). (2) there was no correlation between smell score and egfr-mdrd, serum albumin or cholesterol level. (3) smell scores were not differ between DM and non-dm patients and between male and female.

36 Summary-(2) 3. Smell scores of ESRD patients increased significantly after initiation of hemodialysis and peritoneal dialysis. 4. Improvement of smell scores following dialysis had no relation to gender, diabetes, or age.

37 Limitation Relatively small sample size. Not age- & sex-matched. Prospective, but no randomized controlled study. No longitudinal prospective study.

38 Conclusions These results suggest that. (1) Smell disturbance in patients with ESRD could be recovered by initiation of dialysis. (2) Recovery of olfactory function may be associated with removal of uremic toxin by adequate dialysis. Prospective longitudinal research is required to clarify whether recovery of olfactory function contribute to better outcomes of morbidity and mortality in ESRD patients.

Macro- and Micronutrient Homeostasis in the Setting of Chronic Kidney Disease. T. Alp Ikizler, MD Vanderbilt University Medical Center

Macro- and Micronutrient Homeostasis in the Setting of Chronic Kidney Disease. T. Alp Ikizler, MD Vanderbilt University Medical Center Macro- and Micronutrient Homeostasis in the Setting of Chronic Kidney Disease T. Alp Ikizler, MD Vanderbilt University Medical Center Nutrition and Chronic Kidney Disease What is the disease itself and

More information

The Effect of Residual Renal Function at the Initiation of Dialysis on Patient Survival

The Effect of Residual Renal Function at the Initiation of Dialysis on Patient Survival ORIGINAL ARTICLE DOI: 10.3904/kjim.2009.24.1.55 The Effect of Residual Renal Function at the Initiation of Dialysis on Patient Survival Seoung Gu Kim 1 and Nam Ho Kim 2 Department of Internal Medicine,

More information

Vascular calcification in stage 5 Chronic Kidney Disease patients on dialysis

Vascular calcification in stage 5 Chronic Kidney Disease patients on dialysis Vascular calcification in stage 5 Chronic Kidney Disease patients on dialysis Seoung Woo Lee Div. Of Nephrology and Hypertension, Dept. of Internal Medicine, Inha Unv. College of Medicine, Inchon, Korea

More information

Malnutrition in advanced CKD

Malnutrition in advanced CKD Malnutrition in advanced CKD Malnutrition Lack of proper nutrition, caused by not having enough to eat, not eating enough of the right things or being unable to use the food that one does eat Jessica Stevenson

More information

Acknowledgements. National Kidney Foundation of Connecticut Mark Perazella. Co-PI Slowing the progression of chronic kidney disease to ESRD

Acknowledgements. National Kidney Foundation of Connecticut Mark Perazella. Co-PI Slowing the progression of chronic kidney disease to ESRD A Practical Approach to Chronic Kidney Disease Management for the Primary Care Practioner: A web-site sponsored by the National Kidney Foundation of Connecticut Robert Reilly, M.D. Acknowledgements National

More information

Applying clinical guidelines treating and managing CKD

Applying clinical guidelines treating and managing CKD Applying clinical guidelines treating and managing CKD Develop patient treatment plan according to level of severity. Source: Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012

More information

Options in Renal Replacement Therapy: When, whom, which? Prof Dr. Serhan Tuğlular Marmara University Medical School Division of Nephrology

Options in Renal Replacement Therapy: When, whom, which? Prof Dr. Serhan Tuğlular Marmara University Medical School Division of Nephrology Options in Renal Replacement Therapy: When, whom, which? Prof Dr. Serhan Tuğlular Marmara University Medical School Division of Nephrology CKD Classification Stage Description GFR (ml/min/1.73.m2) 1 Kidney

More information

Seung Hyeok Han, MD, PhD Department of Internal Medicine Yonsei University College of Medicine

Seung Hyeok Han, MD, PhD Department of Internal Medicine Yonsei University College of Medicine Seung Hyeok Han, MD, PhD Department of Internal Medicine Yonsei University College of Medicine The Scope of Optimal BP BP Reduction CV outcomes & mortality CKD progression - Albuminuria - egfr decline

More information

Irish Practice Nurses Association Annual Conference Tullamore Court Hotel OCTOBER 6 th 2012

Irish Practice Nurses Association Annual Conference Tullamore Court Hotel OCTOBER 6 th 2012 Irish Practice Nurses Association Annual Conference Tullamore Court Hotel OCTOBER 6 th 2012 Susan McKenna Renal Clinical Nurse Specialist Cavan General Hospital Renal patient population ACUTE RENAL FAILURE

More information

Effects of Diabetes Mellitus, Age, and Duration of Dialysis on Parathormone in Chronic Hemodialysis Patients. Hamid Nasri 1, Soleiman Kheiri 2

Effects of Diabetes Mellitus, Age, and Duration of Dialysis on Parathormone in Chronic Hemodialysis Patients. Hamid Nasri 1, Soleiman Kheiri 2 Saudi J Kidney Dis Transplant 2008;19(4):608-613 2008 Saudi Center for Organ Transplantation Saudi Journal of Kidney Diseases and Transplantation Original Article Effects of Diabetes Mellitus, Age, and

More information

The Diabetes Kidney Disease Connection Missouri Foundation for Health February 26, 2009

The Diabetes Kidney Disease Connection Missouri Foundation for Health February 26, 2009 The Diabetes Kidney Disease Connection Missouri Foundation for Health February 26, 2009 Teresa Northcutt, RN BSN Primaris Program Manager, Prevention - CKD MO-09-01-CKD This material was prepared by Primaris,

More information

NATIONAL QUALITY FORUM Renal EM Submitted Measures

NATIONAL QUALITY FORUM Renal EM Submitted Measures NATIONAL QUALITY FORUM Renal EM Submitted Measures Measure ID/ Title Measure Description Measure Steward Topic Area #1662 Percentage of patients aged 18 years and older with a diagnosis of CKD ACE/ARB

More information

De Novo Hypokalemia in Incident Peritoneal Dialysis

De Novo Hypokalemia in Incident Peritoneal Dialysis Original investigation 73 1) De Novo Hypokalemia in Incident Peritoneal Dialysis Patients: A 1-Year Observational Study Ji Yong Jung, M.D., Jae Hyun Chang, M.D., Hyun Hee Lee, M.D., Wookyung Chung, M.D.

More information

Geriatric Nephrology. Murtener Tage

Geriatric Nephrology. Murtener Tage Geriatric Nephrology Murtener Tage 2014 Isabelle.Binet@kssg.ch www.nierenstiftung.ch Plan Geriatric nephrology The elderly with CKD The elderly on dialysis The elderly in transplantation Plan Geriatric

More information

Malnutrition and inflammation in peritoneal dialysis patients

Malnutrition and inflammation in peritoneal dialysis patients Kidney International, Vol. 64, Supplement 87 (2003), pp. S87 S91 Malnutrition and inflammation in peritoneal dialysis patients PAUL A. FEIN, NEAL MITTMAN, RAJDEEP GADH, JYOTIPRAKAS CHATTOPADHYAY, DANIEL

More information

Advances in Peritoneal Dialysis, Vol. 29, 2013

Advances in Peritoneal Dialysis, Vol. 29, 2013 Advances in Peritoneal Dialysis, Vol. 29, 2013 Takeyuki Hiramatsu, 1 Takahiro Hayasaki, 1 Akinori Hobo, 1 Shinji Furuta, 1 Koki Kabu, 2 Yukio Tonozuka, 2 Yoshiyasu Iida 1 Icodextrin Eliminates Phosphate

More information

KMJ Original Article. Ye Na Kim, Ho Sik Shin. Department of Internal Medicine, College of Medicine, Kosin University, Busan, Korea

KMJ Original Article. Ye Na Kim, Ho Sik Shin. Department of Internal Medicine, College of Medicine, Kosin University, Busan, Korea Kosin Medical Journal 2017;32:58-71. https://doi.org/10.7180/kmj.2017.32.1.58 KMJ Original Article Relationships of Total Lymphocyte Count and Subpopulation Lymphocyte Counts with the Nutritional Status

More information

Trial to Reduce. Aranesp* Therapy. Cardiovascular Events with

Trial to Reduce. Aranesp* Therapy. Cardiovascular Events with Trial to Reduce Cardiovascular Events with Aranesp* Therapy John J.V. McMurray, Hajime Uno, Petr Jarolim, Akshay S. Desai, Dick de Zeeuw, Kai-Uwe Eckardt, Peter Ivanovich, Andrew S. Levey, Eldrin F. Lewis,

More information

Effects of Kidney Disease on Cardiovascular Morbidity and Mortality

Effects of Kidney Disease on Cardiovascular Morbidity and Mortality Effects of Kidney Disease on Cardiovascular Morbidity and Mortality Joachim H. Ix, MD, MAS Assistant Professor in Residence Division of Nephrology University of California San Diego, and Veterans Affairs

More information

ISN Mission: Advancing the diagnosis, treatment and prevention of kidney diseases in the developing and developed world

ISN Mission: Advancing the diagnosis, treatment and prevention of kidney diseases in the developing and developed world ISN Mission: Advancing the diagnosis, treatment and prevention of kidney diseases in the developing and developed world Nutrition in Kidney Disease: How to Apply Guidelines to Clinical Practice? T. Alp

More information

Improvement in Pittsburgh Symptom Score Index After Initiation of Peritoneal Dialysis

Improvement in Pittsburgh Symptom Score Index After Initiation of Peritoneal Dialysis Advances in Peritoneal Dialysis, Vol. 24, 2008 Matthew J. Novak, 1 Heena Sheth, 2 Filitsa H. Bender, 1 Linda Fried, 1,3 Beth Piraino 1 Improvement in Pittsburgh Symptom Score Index After Initiation of

More information

End stage renal disease and Protein Energy wasting

End stage renal disease and Protein Energy wasting End stage renal disease and Protein Energy wasting Dr Goh Heong Keong MBBS,MRCP(UK) www.passpaces.com/kidney.htm Introduction Chronic kidney disease- increasing health burden in many countries. The estimated

More information

Nutrition Assessment in CKD

Nutrition Assessment in CKD Nutrition Assessment in CKD Shiaw-Wen Chien, MD, EMBA Division of Nephrology, Department of Medicine, Tungs Taichung MetroHarbor Hospital Taichung, Taiwan September 10, 2017 Outline Introduction Composite

More information

WHEN (AND WHEN NOT) TO START DIALYSIS. Shahid Chandna, Ken Farrington

WHEN (AND WHEN NOT) TO START DIALYSIS. Shahid Chandna, Ken Farrington WHEN (AND WHEN NOT) TO START DIALYSIS Shahid Chandna, Ken Farrington Changing Perspectives Beta blockers 1980s Contraindicated in heart failure Now mainstay of therapy HRT 1990s must Now only if you have

More information

CKD Prevention Program Protocol

CKD Prevention Program Protocol CKD Prevention Program Protocol Taiwan Pathway as an example I. Understanding problems and situations of ESRD/CKD in Taiwan 1. Understanding the ESRD/CKD Burden 1) National Dialysis Registry since 1987

More information

A team s approach to QOL in CKD patients

A team s approach to QOL in CKD patients A team s approach to QOL in CKD patients Edwin Fong MD FRCPC Which Team? Beauty Symmetry Beauty defined Suntanned Narrower face Less fat Fuller lips Bigger distance of eyes Darker eye brows Higher cheek

More information

End-Stage Renal Disease. Anna Vinnikova, M.D. Associate Professor of Medicine Division of Nephrology

End-Stage Renal Disease. Anna Vinnikova, M.D. Associate Professor of Medicine Division of Nephrology End-Stage Renal Disease Anna Vinnikova, M.D. Associate Professor of Medicine Division of Nephrology ESRD : Life with renal replacement therapy CASE: 18 month old male with HUS develops ESRD PD complicated

More information

Pediatric Nutrition and Kidney Disease

Pediatric Nutrition and Kidney Disease Pediatric Nutrition and Kidney Disease Loai Eid, MD, MSHS, FAAP Consultant Pediatric Nephrologist Pediatric Nephrology & Hypertension Division Chief Dubai Hospital - DHA 26 th October, 2017 Objectives

More information

Cardiovascular Mortality: General Population vs ESRD Dialysis Patients

Cardiovascular Mortality: General Population vs ESRD Dialysis Patients Cardiovascular Mortality: General Population vs ESRD Dialysis Patients Annual CVD Mortality (%) 100 10 1 0.1 0.01 0.001 25-34 35-44 45-54 55-64 66-74 75-84 >85 Age (years) GP Male GP Female GP Black GP

More information

Chronic Kidney Disease. Dr Mohan B. Biyani A. Professor of Medicine University of Ottawa/Ottawa Hospital

Chronic Kidney Disease. Dr Mohan B. Biyani A. Professor of Medicine University of Ottawa/Ottawa Hospital Chronic Kidney Disease Dr Mohan B. Biyani A. Professor of Medicine University of Ottawa/Ottawa Hospital Health Seminar Series Date 12 May 2013 Objectives Normal functioning of Kidneys. Risk factors to

More information

Acute kidney injury and outcomes in acute decompensated heart failure in Korea

Acute kidney injury and outcomes in acute decompensated heart failure in Korea Acute kidney injury and outcomes in acute decompensated heart failure in Korea Mi-Seung Shin 1, Seong Woo Han 2, Dong-Ju Choi 3, Eun Seok Jeon 4, Jae-Joong Kim 5, Myeong-Chan Cho 6, Shung Chull Chae 7,

More information

Status of the CKD and ESRD treatment: Growth, Care, Disparities

Status of the CKD and ESRD treatment: Growth, Care, Disparities Status of the CKD and ESRD treatment: Growth, Care, Disparities United States Renal Data System Coordinating Center An J. Collins, MD FACP Director USRDS Coordinating Center Robert Foley, MB Co-investigator

More information

Cardiovascular Diseases in CKD

Cardiovascular Diseases in CKD 1 Cardiovascular Diseases in CKD Hung-Chun Chen, MD, PhD. Kaohsiung Medical University Taiwan Society of Nephrology 1 2 High Prevalence of CVD in CKD & ESRD Foley RN et al, AJKD 1998; 32(suppl 3):S112-9

More information

Vitamin D receptor gene polymorphism and serum levels of Fetuin-A, Vitamin D and ipth in the hemodialysis patients

Vitamin D receptor gene polymorphism and serum levels of Fetuin-A, Vitamin D and ipth in the hemodialysis patients In The Name of GOD Vitamin D receptor gene polymorphism and serum levels of Fetuin-A, Vitamin D and ipth in the hemodialysis patients Authors & Affiliations: 1-jamal hallajzadeh; Maraghe University of

More information

Nutrition Dilemmas, Controversies & Issues CHRONIC KIDNEY DISEASE (CKD)

Nutrition Dilemmas, Controversies & Issues CHRONIC KIDNEY DISEASE (CKD) Nutrition Dilemmas, Controversies & Issues CHRONIC KIDNEY DISEASE (CKD) Objectives To discuss the role of nutrition in clinical outcomes of chronic kidney disease (CKD) To discuss and update on the nutrition

More information

Nutritional Cases with CKD HEMODIALYSIS

Nutritional Cases with CKD HEMODIALYSIS Nutritional Cases with CKD HEMODIALYSIS S. Muge DEGER, MD, FISN Yuksek Ihtisas University Faculty of Medicine, Koru Hospital Department of Nephrology Ankara, TURKEY CASE-1 BC, is a 60- year- old Caucasian

More information

Screening and early recognition of CKD. John Ngigi (FISN) Kidney specialist

Screening and early recognition of CKD. John Ngigi (FISN) Kidney specialist Screening and early recognition of CKD John Ngigi (FISN) Kidney specialist screening Why? Who? When? How? Primary diagnosis for patients who start dialysis Other 10% Glomerulonephritis 13% No. of dialysis

More information

SERUM CYSTATIN C CONCENTRATION IS A POWERFUL PROGNOSTIC INDICATOR IN PATIENTS WITH CIRRHOTIC ASCITES

SERUM CYSTATIN C CONCENTRATION IS A POWERFUL PROGNOSTIC INDICATOR IN PATIENTS WITH CIRRHOTIC ASCITES SERUM CYSTATIN C CONCENTRATION IS A POWERFUL PROGNOSTIC INDICATOR IN PATIENTS WITH CIRRHOTIC ASCITES YEON SEOK SEO, 1 SOO YOUNG PARK, 2 MOON YOUNG KIM, 3 SANG GYUNE KIM, 4 JUN YONG PARK, 5 HYUNG JOON YIM,

More information

COGNITIVE ALTERATIONS IN CHRONIC KIDNEY DISEASE K K L E E

COGNITIVE ALTERATIONS IN CHRONIC KIDNEY DISEASE K K L E E COGNITIVE ALTERATIONS IN CHRONIC KIDNEY DISEASE K K L E E Attention Problem Solving Language Cognitive Domains Decision Making Memory Reasoning The Cardiovascular Health Cognition Study shows higher S

More information

SAMPLE. Chronic Kidney Disease, Evidence-Based Practice, and the Nutrition Care Process. Chapter 1

SAMPLE. Chronic Kidney Disease, Evidence-Based Practice, and the Nutrition Care Process. Chapter 1 Chapter 1 Chronic Kidney Disease, Evidence-Based Practice, and the Nutrition Care Process This guide follows the steps of the Nutrition Care Process (NCP) nutrition assessment, nutrition diagnosis, nutrition

More information

Renal Replacement Therapy - Indication and Follow up

Renal Replacement Therapy - Indication and Follow up Renal Replacement Therapy - Indication and Follow up Prof Brigadier General Mamun Mostafi FCPS, FRCP Chief Physician Combined Military Hospital Dhaka Bangladesh Primary Functions of the Kidney Removal

More information

Dialysis Initiation and Optimal Vascular Access: Outcomes and Mortality

Dialysis Initiation and Optimal Vascular Access: Outcomes and Mortality Dialysis Initiation and Optimal Vascular Access: Outcomes and Mortality Shannon H. Norris, BSN, RN June 6, 2018 Dialysis Initiation and Optimal Vascular Access: Outcomes and Mortality DISCUSSION: End Stage

More information

Epidemiology of kidney diseases in children

Epidemiology of kidney diseases in children Epidemiology of kidney diseases in children Dr Lesley Rees Gt Ormond St Hospital for Children, London, UK September 2015 Definition of Epidemiology The patterns, causes, and effects of health and diseases

More information

Difference in practical dialysis therapy between East Asia and US/EU

Difference in practical dialysis therapy between East Asia and US/EU Difference in practical dialysis therapy between East Asia and US/EU Jer-Ming Chang. M.D., Ph.D. 1 Professor, Attending physician, Kaohsiung Medical University Hospital; 2 Secretary General, Taiwan Society

More information

Intradialytic Parenteral Nutrition in Hemodialysis Patients. Hamdy Amin, Pharm.D., MBA, BCNSP Riyadh, Saudi Arabia

Intradialytic Parenteral Nutrition in Hemodialysis Patients. Hamdy Amin, Pharm.D., MBA, BCNSP Riyadh, Saudi Arabia Intradialytic Parenteral Nutrition in Hemodialysis Patients Hamdy Amin, Pharm.D., MBA, BCNSP Riyadh, Saudi Arabia Disclosure Information Intradialytic Parenteral Nutrition in Hemodialysis Patients Hamdy

More information

Addressing Chronic Kidney Disease in People with Multiple Chronic Conditions

Addressing Chronic Kidney Disease in People with Multiple Chronic Conditions Addressing Chronic Kidney Disease in People with Multiple Chronic Conditions Andrew S Narva, MD Na/onal Kidney Disease Educa/on Program U.S. Department of Health and Human Services National Institute of

More information

Objectives. Pre-dialysis CKD: The Problem. Pre-dialysis CKD: The Problem. Objectives

Objectives. Pre-dialysis CKD: The Problem. Pre-dialysis CKD: The Problem. Objectives The Role of the Primary Physician and the Nephrologist in the Management of Chronic Kidney Disease () By Brian Young, M.D. Assistant Clinical Professor of Medicine David Geffen School of Medicine at UCLA

More information

PART ONE. Peritoneal Kinetics and Anatomy

PART ONE. Peritoneal Kinetics and Anatomy PART ONE Peritoneal Kinetics and Anatomy Advances in Peritoneal Dialysis, Vol. 22, 2006 Paul A. Fein, Irfan Fazil, Muhammad A. Rafiq, Teresa Schloth, Betty Matza, Jyotiprakas Chattopadhyay, Morrell M.

More information

The Intact Nephron Hypothesis in Reverse: An Argument In Favor of Incremental Initiation Of Dialysis (With Residual Kidney Function)

The Intact Nephron Hypothesis in Reverse: An Argument In Favor of Incremental Initiation Of Dialysis (With Residual Kidney Function) The Intact Nephron Hypothesis in Reverse: An Argument In Favor of Incremental Initiation Of Dialysis (With Residual Kidney Function) Thomas A. Golper MD, FACP, FASN Vanderbilt University Medical Center

More information

morbidity & mortality

morbidity & mortality morbidity & mortality esrd introduction of ESRD treatment. We examine these concerns throughout the ADR, particularly in Chapter One. This year we focus on infectious complications, especially those related

More information

Outcomes of dialysis in the elderly. DNT March 2011 Dr Céline Foote

Outcomes of dialysis in the elderly. DNT March 2011 Dr Céline Foote Outcomes of dialysis in the elderly DNT March 2011 Dr Céline Foote Increasing number of elderly patients on renal replacement therapy 500 500 Patients per million 400 300 200 100 400 300 200 100 TOTAL

More information

Chronic Kidney Disease. Basics of CKD Terms Diagnosis Management

Chronic Kidney Disease. Basics of CKD Terms Diagnosis Management Chronic Kidney Disease Basics of CKD Terms Diagnosis Management Review the prevalence of chronic kidney disease (CKD) Review how CKD develops Review populations at risk for CKD Review CKD diagnosis Objectives

More information

THE KIDNEY AND SLE LUPUS NEPHRITIS

THE KIDNEY AND SLE LUPUS NEPHRITIS THE KIDNEY AND SLE LUPUS NEPHRITIS JACK WATERMAN DO FACOI 2013 NEPHROLOGY SIR RICHARD BRIGHT TERMINOLOGY RENAL INSUFFICIENCY CKD (CHRONIC KIDNEY DISEASE) ESRD (ENDSTAGE RENAL DISEASE) GLOMERULONEPHRITIS

More information

Hemodiafiltration: principles and advantages over conventional HD. Rukshana Shroff Great Ormond Street Hospital for Children London, UK

Hemodiafiltration: principles and advantages over conventional HD. Rukshana Shroff Great Ormond Street Hospital for Children London, UK Hemodiafiltration: principles and advantages over conventional HD Rukshana Shroff Great Ormond Street Hospital for Children London, UK Effectiveness of RRT modalities Mcfarlane, Seminars in dialysis, 2009

More information

Therapeutic golas in the treatment of CKD-MBD

Therapeutic golas in the treatment of CKD-MBD Therapeutic golas in the treatment of CKD-MBD Hemodialysis clinic Clinical University Center Sarajevo Bantao, 04-08.10.2017, Sarajevo Abbvie Satellite symposium 06.10.2017 Chronic Kidney Disease Mineral

More information

Kidney Research and Clinical Practice

Kidney Research and Clinical Practice Kidney Res Clin Pract 33 (214) 9 18 Kidney Research and Clinical Practice journal homepage: http://www.krcp-ksn.com Contents lists available at ScienceDirect Special Article Renal replacement therapy in

More information

Predicting and changing the future for people with CKD

Predicting and changing the future for people with CKD Predicting and changing the future for people with CKD I. David Weiner, M.D. Co-holder, C. Craig and Audrae Tisher Chair in Nephrology Professor of Medicine and Physiology and Functional Genomics University

More information

Variable Included. Excluded. Included. Excluded

Variable Included. Excluded. Included. Excluded Table S1. Baseline characteristics of patients included in the analysis and those excluded patients because of missing baseline serumj bicarbonate levels, stratified by dialysis modality. Variable HD patients

More information

NUTRITION CONSIDERATIONS FOR PATIENTS WITH DIABETIC NEPHROPATHY

NUTRITION CONSIDERATIONS FOR PATIENTS WITH DIABETIC NEPHROPATHY NUTRITION CONSIDERATIONS FOR PATIENTS WITH DIABETIC NEPHROPATHY Becca Wallschlaeger, MS RDN CD Transplant Nutritionist University of Wisconsin Transplant Program Fall 2017 OBJECTIVES Recognize kidney disease

More information

Narender Goel et al. Middletown Medical PC, Montefiore Medical Center & Albert Einstein College of Medicine, New York

Narender Goel et al. Middletown Medical PC, Montefiore Medical Center & Albert Einstein College of Medicine, New York Narender Goel et al. Middletown Medical PC, Montefiore Medical Center & Albert Einstein College of Medicine, New York 4th International Conference on Nephrology & Therapeutics September 14, 2015 Baltimore,

More information

Ca, Phos and Vitamin D Metabolism in Pre-Dialysis Patients

Ca, Phos and Vitamin D Metabolism in Pre-Dialysis Patients Ca, Phos and Vitamin D Metabolism in Pre-Dialysis Patients A. WADGYMAR, MD Credit Valley Hospital, Mississauga, Ontario, Canada. June 1, 2007 1 Case: 22 y/o referred to Renal Clinic Case: A.M. 29 y/o Man

More information

The Egyptian Journal of Hospital Medicine (October 2017) Vol.69(1), Page

The Egyptian Journal of Hospital Medicine (October 2017) Vol.69(1), Page The Egyptian Journal of Hospital Medicine (October 2017) Vol.69(1), Page 1589-1594 Using Serum Beta Trace Protein to Estimate Residual Kidney Function in Hemodialysis Patients Hesham M. El-Sayed, Hussein

More information

Tread Carefully Because you Tread on my Nephrons. Prescribing Hints in Renal Disease

Tread Carefully Because you Tread on my Nephrons. Prescribing Hints in Renal Disease Tread Carefully Because you Tread on my Nephrons Prescribing Hints in Renal Disease David WP Lappin,, MB PhD FRCPI Clinical Lecturer in Medicine and Consultant Nephrologist and General Physician, Merlin

More information

The future is here. It s just not widely distributed yet. William Gibson

The future is here. It s just not widely distributed yet. William Gibson The future is here. It s just not widely distributed yet. William Gibson CHRONIC KIDNEY DISEASE MANAGEMENT A NEW PARADIGM Aaron Cass, MD, FRCPC Nephrologist, Fraser Health January 22, 2014 Where Are We

More information

Outline. Outline CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW. Question 1: Which of these patients has CKD?

Outline. Outline CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW. Question 1: Which of these patients has CKD? CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH CHIEF-GENERAL INTERNAL MEDICINE, SAN FRANCISCO VA MEDICAL CENTER PROFESSOR OF MEDICINE, EPIDEMIOLOGY AND BIOSTATISTICS,

More information

Update on HIV-Related Kidney Diseases. Agenda

Update on HIV-Related Kidney Diseases. Agenda Update on HIV-Related Kidney Diseases ANDY CHOI THE MEDICAL MANAGEMENT OF HIV/AIDS DECEMBER 15, 2006 Agenda 1. EPIDEMIOLOGY: A) END STAGE RENAL DISEASE (ESRD) B) CHRONIC KIDNEY DISEASE (CKD) 2. HIV-ASSOCIATED

More information

CKD & HT. Anne-Marie Angus

CKD & HT. Anne-Marie Angus CKD & HT Anne-Marie Angus Hypertension definitions Persisting BP >140/90 and HBPM >135/85 Stage 1 >140/90 (HBPM >135/85) Stage 2 >160/100 (HBPM >150/90) Severe >180/100 White coat HT Why treat? A major

More information

BONE AND MINERAL METABOLISM in the PD PATIENT

BONE AND MINERAL METABOLISM in the PD PATIENT BONE AND MINERAL METABOLISM in the PD PATIENT John Burkart, MD Professor of Medicine/Nephrology Wake Forest University Baptist Medical Center Chief Medical Officer Health Systems Management Maria V. DeVita,

More information

Dr A Pokrajac MD MSc MRCP Consultant

Dr A Pokrajac MD MSc MRCP Consultant Dr A Pokrajac MD MSc MRCP Consultant Onset at 5-15 years of T1DM Can be present at diagnosis of T2DM Detect in regular MA/Cr screening (2X first urine sample, no UTI, no other causes) Contributing Factors

More information

21th Budapest Nephrology School Ágnes Haris, Kálmán Polner

21th Budapest Nephrology School Ágnes Haris, Kálmán Polner 21th Budapest Nephrology School Ágnes Haris, Kálmán Polner 53 years old female, -worked as computer scientist, -lived with her husband and 2 children, -in excellent financial situation. Diagnosed with

More information

Management of Early Kidney Disease: What to do Before Referring to the Nephrologist

Management of Early Kidney Disease: What to do Before Referring to the Nephrologist Management of Early Kidney Disease: What to do Before Referring to the Nephrologist Andrew S. Narva, MD, NIDDK Saturday, February 18, 2017 8:45 a.m. 9:30 a.m. Although evidence-based guidelines for managing

More information

Lesson #7: Quality Assessment and Performance Improvement

Lesson #7: Quality Assessment and Performance Improvement ESRD Update: Transitioning to New ESRD Conditions for Coverage Student Manual Lesson #7: Quality Assessment and Performance Improvement Learning Objectives At the conclusion of this lesson, you will be

More information

Cardiovascular Risk Reduction in Kidney Transplant Recipients

Cardiovascular Risk Reduction in Kidney Transplant Recipients Cardiovascular Risk Reduction in Kidney Transplant Recipients Rainer Oberbauer R.O. AUG 2010 CV Mortality in ESRD compared to the general population R.O.2/32 Modified from Foley et al. AJKD 32 (suppl3):

More information

Morbidity & Mortality from Chronic Kidney Disease

Morbidity & Mortality from Chronic Kidney Disease Morbidity & Mortality from Chronic Kidney Disease Dr. Lam Man-Fai ( 林萬斐醫生 ) Honorary Clinical Assistant Professor MBBS, MRCP, FHKCP, FHKAM, PDipID (HK), FRCP (Edin, Glasg) Hong Kong Renal Registry Report

More information

Chapter Five Clinical indicators & preventive health

Chapter Five Clinical indicators & preventive health Chapter Five Clinical indicators & preventive health The painter who draws merely by practice and by eye, without any reason, is like a mirror which copies every thing placed in front of it without being

More information

HEALTHYSTART TRAINING MANUAL. Living well with Kidney Disease

HEALTHYSTART TRAINING MANUAL. Living well with Kidney Disease HEALTHYSTART TRAINING MANUAL Living well with Kidney Disease KIDNEY DISEASE CAN AFFECT ANYONE! 1 HEALTHYSTART PROGRAMME HEALTHYSTART is a lifestyle management programme to assist you to remain healthy

More information

The Effect of High-Flux Hemodialysis on Dialysis-Associated Amyloidosis

The Effect of High-Flux Hemodialysis on Dialysis-Associated Amyloidosis Renal Failure, 1:31-34, 2005 Copyright 2005 Taylor & Francis Inc. ISSN: 0886-022X print / 1525-6049 online DOI: 10.1081/JDI-200042868 Taylor & Francis Taylor 6. Francis Croup CLINICAL STUDY The Effect

More information

Home Hemodialysis or Transplantation of the Treatment of Choice for Elderly?

Home Hemodialysis or Transplantation of the Treatment of Choice for Elderly? Home Hemodialysis or Transplantation of the Treatment of Choice for Elderly? Miklos Z Molnar, MD, PhD, FEBTM, FERA, FASN Associate Professor of Medicine Division of Nephrology, Department of Medicine University

More information

Protecting the heart and kidney: implications from the SHARP trial

Protecting the heart and kidney: implications from the SHARP trial Cardiology Update, Davos, 2013: Satellite Symposium Protecting the heart and kidney: implications from the SHARP trial Colin Baigent Professor of Epidemiology CTSU, University of Oxford S1 First CTT cycle:

More information

Nephrology Unit- CHU Liège- Ulg- Belgium

Nephrology Unit- CHU Liège- Ulg- Belgium Are the complications of arteriovenous fistulas associated with an abnormal Ankle-Brachial Index in Hemodialysis? A 4y study P. Xhignesse, A. Saint-Remy, B. Dubois, JC. Philips, JM. Krzesinski Nephrology

More information

CKD FOR PRIMARY CARE MINNESOTA ACADEMY OF PHYSICIANS 2017 HEATHER ANN MUSTER, MD MS

CKD FOR PRIMARY CARE MINNESOTA ACADEMY OF PHYSICIANS 2017 HEATHER ANN MUSTER, MD MS CKD FOR PRIMARY CARE MINNESOTA ACADEMY OF PHYSICIANS 2017 HEATHER ANN MUSTER, MD MS PLoS One. 2014 Nov 26;9(11):e110535. Of the 445 PCPs who enrolled at least 10 patients, 19 (4.3%) had >50% likelihood

More information

Role of High-sensitivity C-reactive Protein as a Marker of Inflammation in Pre-dialysis Patients of Chronic Renal Failure

Role of High-sensitivity C-reactive Protein as a Marker of Inflammation in Pre-dialysis Patients of Chronic Renal Failure ORIGINAL ARTICLE JIACM 2009; 10(1 & 2): 18-22 Abstract Role of High-sensitivity C-reactive Protein as a Marker of Inflammation in Pre-dialysis Patients of Chronic Renal Failure N Nand*, HK Aggarwal**,

More information

The vexing problem of suboptimal initiation of dialysis: Can we do better?

The vexing problem of suboptimal initiation of dialysis: Can we do better? Budapest Nephrology School August 30, 2010 The vexing problem of suboptimal initiation of dialysis: Can we do better? David C Mendelssohn Disclosures 2007 2010 Speaker Fees: Amgen, Ortho Biotech, Genzyme,

More information

Ipovitaminosi D e metabolismo calcio-fosforo in dialisi peritoneale. Maurizio Gallieni Università degli Studi di Milano

Ipovitaminosi D e metabolismo calcio-fosforo in dialisi peritoneale. Maurizio Gallieni Università degli Studi di Milano Ipovitaminosi D e metabolismo calcio-fosforo in dialisi peritoneale Maurizio Gallieni Università degli Studi di Milano G Ital Nefrol 2018 - ISSN 1724-5990 Nutrients 2017, 9, 328 Vitamin D deficiency (

More information

Renal Disease and PK/PD. Anjay Rastogi MD PhD Division of Nephrology

Renal Disease and PK/PD. Anjay Rastogi MD PhD Division of Nephrology Renal Disease and PK/PD Anjay Rastogi MD PhD Division of Nephrology Drugs and Kidneys Kidney is one of the major organ of drug elimination from the human body Renal disease and dialysis alters the pharmacokinetics

More information

Stefanos K. Roumeliotis. Department of Nephrology, Medical School Democritus University of Thrace, Alexandroupolis, Greece. Stefanos K.

Stefanos K. Roumeliotis. Department of Nephrology, Medical School Democritus University of Thrace, Alexandroupolis, Greece. Stefanos K. Department of Nephrology, Medical School Democritus University of Thrace, Alexandroupolis, Greece Passive, degenerative accumulation process of Ca ++ /P +++ without treatment options Active, complex, condition:

More information

Systolic Blood Pressure Intervention Trial (SPRINT)

Systolic Blood Pressure Intervention Trial (SPRINT) 09:30-09:50 2016.4.15 Systolic Blood Pressure Intervention Trial (SPRINT) IN A NEPHROLOGIST S VIEW Sejoong Kim Seoul National University Bundang Hospital Current guidelines for BP control Lowering BP

More information

State Profile for FY 2018 for Dialysis Patients and Facilities - STATE SAMPLE

State Profile for FY 2018 for Dialysis Patients and Facilities - STATE SAMPLE Dear State Surveyor: State Profile for FY 2018 for Dialysis Patients and Facilities - STATE SAMPLE This report is designed to provide a comparative summary of treatment patterns and patient outcomes for

More information

Prevalence of Access Recirculation in Prevalent Arterio-Venous (A-V) Fistula Hemodialysis Patients and Its Effect on Hemodialysis Adequacy

Prevalence of Access Recirculation in Prevalent Arterio-Venous (A-V) Fistula Hemodialysis Patients and Its Effect on Hemodialysis Adequacy The Egyptian Journal of Hospital Medicine (July 2018) Vol. 72 (6), Page 4602-4609 Prevalence of Access Recirculation in Prevalent Arterio-Venous (A-V) Fistula Hemodialysis Patients and Its Effect on Hemodialysis

More information

What should you do next? Presenter Disclosure Information. Learning Objectives. Case: George

What should you do next? Presenter Disclosure Information. Learning Objectives. Case: George 2:45 3:45pm Optimizing the Management of Patients with Chronic Kidney Disease SPEAKER Jay B. Wish, MD, FACP Presenter Disclosure Information The following relationships exist related to this presentation:

More information

Aging and renal diseases - Clinical management, treatment, ethics and complications

Aging and renal diseases - Clinical management, treatment, ethics and complications ... Aging and renal diseases - Clinical management, treatment, ethics and complications Gijs Van Pottelbergh (ACHG KULeuven, IRSS UCLouvain), Pierre Wallemacq and Jan Degryse Overview Is there a high prevalence

More information

Primary Care Physicians and Clinicians. XXX on behalf of the Upper Midwest Fistula First Coalition. Chronic Kidney Disease (CKD) Resources

Primary Care Physicians and Clinicians. XXX on behalf of the Upper Midwest Fistula First Coalition. Chronic Kidney Disease (CKD) Resources August 10, 2007 To: From: RE: Primary Care Physicians and Clinicians XXX on behalf of the Upper Midwest Fistula First Coalition Chronic Kidney Disease (CKD) Resources Caring for patients with chronic kidney

More information

egfr 34 ml/min egfr 130 ml/min Am J Kidney Dis 2002;39(suppl 1):S17-S31

egfr 34 ml/min egfr 130 ml/min Am J Kidney Dis 2002;39(suppl 1):S17-S31 Update on Renal Therapeutics Caroline Ashley Lead Pharmacist Renal Services UCL Centre for Nephrology, Royal Free Hospital, London Kongress für Arzneimittelinformation January 2011 What are we going to

More information

Outline. Outline CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW 7/23/2013. Question 1: Which of these patients has CKD?

Outline. Outline CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW 7/23/2013. Question 1: Which of these patients has CKD? CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH CHIEF-GENERAL INTERNAL MEDICINE, SAN FRANCISCO VA MEDICAL CENTER PROFESSOR OF MEDICINE, EPIDEMIOLOGY AND BIOSTATISTICS,

More information

K atching Up with KDOQI: Clinical Practice Guidelines & Clinical Practice Recommendations for Anemia of Chronic Kidney Disease 2006

K atching Up with KDOQI: Clinical Practice Guidelines & Clinical Practice Recommendations for Anemia of Chronic Kidney Disease 2006 K atching Up with KDOQI: Clinical Practice Guidelines & Clinical Practice Recommendations for Anemia of Chronic Kidney Disease 2006 Why new guidelines? Rationale for KDOQI Anemia 2006 Expand scope to all

More information

Chronic kidney disease-what can you do and when to refer?

Chronic kidney disease-what can you do and when to refer? Chronic kidney disease-what can you do and when to refer? Dr Goh Heong Keong www.passpaces.com/kidney.htm Outline of Lecture Introduction Epidemiology of CKD in Malaysia/ World Complications of CKD What

More information

PREVALENCE AND PATTERNS OF HYPERPARATHYROIDISM AND MINERAL BONE DISEASE IN PATIENTS WITH CHRONIC KIDNEY DISEASE AT KENYATTA NATIONAL HOSPITAL

PREVALENCE AND PATTERNS OF HYPERPARATHYROIDISM AND MINERAL BONE DISEASE IN PATIENTS WITH CHRONIC KIDNEY DISEASE AT KENYATTA NATIONAL HOSPITAL PREVALENCE AND PATTERNS OF HYPERPARATHYROIDISM AND MINERAL BONE DISEASE IN PATIENTS WITH CHRONIC KIDNEY DISEASE AT KENYATTA NATIONAL HOSPITAL DR. ANNE MUGERA The Problem Chronic Kidney disease is a worldwide

More information

Chronic Kidney Disease

Chronic Kidney Disease Chronic Kidney Disease Chronic Kidney Disease (CKD) Educational Objectives Outline Demographics Propose Strategies to slow progression and improve outcomes Plan for treatment of CKD Chronic Kidney Disease

More information

Nephrology. Renal Replacement in End-Stage Renal Disease Patients over 75 Years Old. ABC Fax

Nephrology. Renal Replacement in End-Stage Renal Disease Patients over 75 Years Old. ABC Fax American Journal of Nephrology Original Article: Basic Sciences Am J Nephrol 2003;23:7 77 DOI: 0.59/000068040 Received: July 23, 2002 Accepted: October 2, 2002 Renal Replacement in End-Stage Renal Disease

More information

SERUM AMYLASE IN PATIENTS WITH CHRONIC KIDNEY

SERUM AMYLASE IN PATIENTS WITH CHRONIC KIDNEY SERUM AMYLASE IN PATIENTS WITH CHRONIC KIDNEY DISEASE IJCRR Vol 05 issue 17 Section: Healthcare Category: Case Study Received on: 28/07/12 Revised on: 19/08/13 Accepted on: 04/09/13 Bindu C. M. 1, Vidya

More information